Solubility Advantage of Amorphous Pharmaceuticals, Part 3: Is Maximum Solubility Advantage Experimentally Attainable and Sustainable?

Title
Solubility Advantage of Amorphous Pharmaceuticals, Part 3: Is Maximum Solubility Advantage Experimentally Attainable and Sustainable?
Authors
Keywords
-
Journal
JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 100, Issue 10, Pages 4349-4356
Publisher
Elsevier BV
Online
2011-06-01
DOI
10.1002/jps.22643

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now